HUTCHMED (China) (HMDCF) Non-Current Assets (2015 - 2025)
HUTCHMED (China) (HMDCF) reported Non-Current Assets of $66.1 million for Q4 2025, down 2.15% year-over-year from $67.6 million in Q4 2024, and down 63.99% quarter-over-quarter from $183.6 million in Q2 2025.
HUTCHMED (China) (HMDCF) Non-Current Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 11 years of Non-Current Assets data on file, last reported at $66.1 million in Q4 2025.
- Non-Current Assets for Q4 2025 came in at $66.1 million, down 2.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $66.1 million (down 2.15% YoY), and the FY2025 annual result was $66.1 million, down 2.15% from the prior year.
- Non-Current Assets declined to $66.1 million in Q4 2025 per HMDCF's latest filing, from $183.6 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $196.9 million in Q1 2021 and troughed at -$925.0 million in Q2 2023.
- A 5-year average of -$63.5 million and a median of $80.1 million in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets sank 637.48% in 2023, then jumped 120.7% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $91.6 million in 2021, then fell by 12.6% to $80.1 million in 2022, then dropped by 7.65% to $73.9 million in 2023, then decreased by 8.63% to $67.6 million in 2024, then slipped by 2.15% to $66.1 million in 2025.
- Business Quant data shows HMDCF's Non-Current Assets at $66.1 million in Q4 2025, $183.6 million in Q2 2025, and $67.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | HUTCHMED (China) | - | - | - | 66.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.11 Mn |
| Jun 30, 2025 | 183.61 Mn |
| Dec 31, 2024 | 67.56 Mn |
| Jun 30, 2024 | -886.97 Mn |
| Dec 31, 2023 | 73.94 Mn |
| Jun 30, 2023 | -924.98 Mn |
| Dec 31, 2022 | 80.06 Mn |
| Jun 30, 2022 | 172.10 Mn |
| Dec 31, 2021 | 91.61 Mn |
| Jun 30, 2021 | 181.72 Mn |
| Mar 31, 2021 | 196.89 Mn |
| Dec 31, 2020 | 93.36 Mn |
| Jun 30, 2020 | 91.43 Mn |
| Dec 31, 2019 | 95.10 Mn |
| Sep 30, 2019 | 177.01 Mn |
| Jun 30, 2019 | 185.72 Mn |
| Mar 31, 2019 | 189.30 Mn |
| Dec 31, 2018 | 161.58 Mn |
| Jun 30, 2018 | 183.27 Mn |
| Dec 31, 2017 | 107.23 Mn |